Brief: Casi Pharmaceuticals Inc And Casi Pharmaceuticals Holdings Entered Into A Definitive Agreement And Plan Of Merger
31/01/2023 22:31
Jan 31 (Reuters) - CASI Pharmaceuticals Inc CASI.O :
* CASI PHARMACEUTICALS INC - CO AND CASI PHARMACEUTICALS
HOLDINGS
ENTERED INTO A DEFINITIVE AGREEMENT AND PLAN OF MERGER
* CASI PHARMACEUTICALS INC - CO WILL MERGE WITH AND INTO
CASI
CAYMAN WITH CASI CAYMAN SURVIVING, CHANGING NAME TO CASI
PHARMACEUTICALS, INC
Further company coverage: CASI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CASI Pharmaceuticals
See all newsBrief: Casi Pharmaceuticals Reports The Receipt Of Drug Registration Certificate For Thiotepa In China
CASI Pharmaceuticals Q3 revenue drops 60%, net loss widens
Brief: CASI Pharmaceuticals Inc Reports The Expiration Of Import Drug Registration License For Folotyn® In China
Casi Pharmaceuticals Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview
Casi Pharmaceuticals Inc Reports Results For The Quarter Ended March 31: Earnings Summary